EPH247 Pain and Arthralgia Adverse Events Associated with Crizanlizumab and Voxelotor: Disproportionality Analysis of US FDA Adverse Events Reporting System (FAERS)

Autor: Ologunowa, A., Caffrey, A.R.
Zdroj: In Value in Health June 2023 26(6) Supplement:S208-S208
Databáze: ScienceDirect